Precision Therapy for Advanced Cholangiocarcinoma: Focus on FGFR Inhibitors

Share

Program Content

Activities

  • Precision Therapy for Advanced Cholangiocarcinoma: Focus on FGFR Inhibitors
    Precision Therapy for Advanced Cholangiocarcinoma: Focus on FGFR Inhibitors
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 25, 2022

    Expires: May 24, 2023

Faculty

cover img faculity

Philip A. Philip, MD, PhD, FRCP

Professor
School of Medicine
Wayne State University
Leader
Gastrointestinal Multidisciplinary Team
Department of Oncology
Henry Ford Cancer Institute
Detroit, Michigan

Provided by

ProCE Banner

Supporters

Incyte Corporation